Direct Biologics

Direct Biologics is a biotechnology company focused on advancing research in biologics through its “Natural Intelligence” approach, which applies naturally derived biological systems and processes to therapeutic development. The company develops investigational, secretome-based product candidates derived from adult bone marrow mesenchymal stem cells for evaluation in clinical research. Its work includes studying extracellular vesicles, small particles released by cells, alongside proteins, lipids, and other biomolecules that make up the broader secretome.

Direct Biologics brings together scientific research, manufacturing, and clinical research to support development of its candidate therapies. Its current good manufacturing practice (cGMP) processes are designed to support consistency, scalability, and quality from sourcing through characterization. The company’s stated core values are Safety, Innovation, and Quality, guiding its efforts to advance clinical research programs. Direct Biologics emphasizes that its product candidates are investigational and have not been approved by the U.S. Food and Drug Administration. Based in Austin, Texas, the company also offers career opportunities and provides information about its science, technology, pipeline, and clinical trials.